Neurology, Vol 45, Issue 5 987-988, Copyright © 1995 by American Academy of Neurology

ARTICLES

Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin

LH Van den Berg, H Franssen and JH Wokke
Department of Neurology, Rudolf Magnus Research School in the Neurosciences, University Hospital Utrecht, The Netherlands.

In multifocal motor neuropathy (MMN), little is known of the long-term effect of human immunoglobulin (HIG) infusions as a maintenance therapy. We report a patient who improved after an initial HIG infusion of 2 g/kg and continued to improve both clinically and electrophysiologically during maintenance HIG treatment consisting of one infusion of 0.4 g/kg every week. Our findings suggest that maintenance HIG therapy may lead to further improvement of MMN, and that more frequent HIG infusions at a lower dosage may be more effective.

This article has been cited by other articles:

				J-M Leger, K Viala, F Cancalon, T Maisonobe, B Gruwez, T Waegemans, and P Bouche Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 93 - 96. [Abstract] [Full Text] [PDF]

				M. Slee, A. Selvan, and M. Donaghy Multifocal motor neuropathy: The diagnostic spectrum and response to treatment Neurology, October 23, 2007; 69(17): 1680 - 1687. [Abstract] [Full Text] [PDF]

				R. M. Van den Berg-Vos, H. Franssen, J. H. J. Wokke, and L. H. V. d. Berg Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment Brain, August 1, 2002; 125(8): 1875 - 1886. [Abstract] [Full Text] [PDF]

				P. Federico, D.W. Zochodne, A.F. Hahn, W.F. Brown, and T. E. Feasby Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study Neurology, November 14, 2000; 55(9): 1256 - 1262. [Abstract] [Full Text] [PDF]

				W. M. J. Bosboom, L. H. Van den Berg, L. De Boer, M. J. Van Son, H. Veldman, H. Franssen, T. Logtenberg, and J. H. J. Wokke The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy Neurology, September 1, 1999; 53(4): 837 - 837. [Abstract] [Full Text] [PDF]

				P. S. Sorensen Intravenous Immunoglobulin Treatment in Neurologic Disorders: Yes Arch Neurol, August 1, 1999; 56(8): 1025 - 1027. [Full Text] [PDF]

				C M Ellis, S Leary, J Payan, C Shaw, M Hu, M O'Brien, and P N Leigh Use of human intravenous immunoglobulin in lower motor neuron syndromes J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 15 - 19. [Abstract] [Full Text]

				N. Meucci, A. Cappellari, S. Barbieri, G. Scarlato, and E. Nobile-Orazio Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 765 - 769. [Abstract] [Full Text] [PDF]

				L H van den Berg, H Franssen, P A Van Doorn, and J H J Wokke Intravenous immunoglobulin treatment in lower motor neuron disease associated with highly raised anti-GM1 antibodies J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 674 - 677. [Abstract] [Full Text] [PDF]